Ascendis Pharma Growth Disorders A/S

Ascendis Pharma Growth Disorders A/S (CVR number: 32323677) is a company from GENTOFTE. The company recorded a gross profit of -57035.7 kEUR in 2022. The operating profit was -57.2 mEUR, while net earnings were -61.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was -31.3 %, which can be considered poor and Return on Equity (ROE) was -530 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -93.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Ascendis Pharma Growth Disorders A/S's liquidity measured by quick ratio was 874.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.